Roblox Corporation is upgraded to a Buy after a 25% stock pullback and a strong Q3 beat-and-raise performance. Learn more ...

As the pandemic's height passed, Carnival's business recovered as global travel resumed. But Roblox struggled as many of its ...

Strong growth in daily users and top-line growth has more than doubled Roblox stock this year. The viral success of the game “Grow a Garden” contributed significantly to Roblox’s second-quarter growth ...

Fintel reports that on October 31, 2025, Needham reiterated coverage of Roblox (NYSE:RBLX) with a Buy recommendation. Analyst Price Forecast Suggests 31.64% Upside As of October 30, 2025, the average ...

Fintel reports that on October 30, 2025, BTIG maintained coverage of Roblox (NYSE:RBLX) with a Buy recommendation. Analyst Price Forecast Suggests 32.37% Upside As of October 30, 2025, the average one ...

Major services were having issues, including WhatsApp, the official website for the British government and the payment app Venmo. By Joel Petterson Hundreds of websites and apps were reporting outages ...

TALLAHASSEE, Fla — Florida Attorney General James Uthmeier is issuing criminal subpoenas to the popular gaming platform Roblox. In a post on social media, Uthmeier says, “Roblox profited off out kids ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Jackson Square Properties has ...

BitMine chairman Tom Lee has confirmed the company went on an Ether buying spree after the crypto market saw one of its most significant deleveraging events earlier this month. “Open interest for ETH ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Learning Experience opened ...

TSMC, chairman, Wei Zhejia said that strong AI demand means the outfit will need to buy a second plot near its new Arizona, US factory to back an expansion push and calm any supply chain jitters.

AstraZeneca Plc got a rare sell rating on Thursday as Deutsche Bank AG analysts downgraded the British drugmaker, taking a more skeptical view on the company’s drug pipeline, in particular for breast ...